Division of Cardiology Vancouver General Hospital Vancouver British Columbia Canada.
BC Centre for Improved Cardiovascular Health UBC Vancouver British Columbia Canada.
J Am Heart Assoc. 2020 Aug 18;9(16):e015834. doi: 10.1161/JAHA.120.015834. Epub 2020 Aug 5.
Background A significant proportion of patients with spontaneous coronary artery dissection (SCAD) have ongoing chronic chest pain despite healing of their dissection. We sought to determine whether coronary microvascular dysfunction contributes to post-SCAD chronic chest pain by performing coronary reactivity testing in the cardiac catheterization laboratory. Methods and Results Eighteen patients consented to coronary reactivity testing at least 3 months post-SCAD. Coronary flow reserve (CFR) and index of microcirculatory resistance were measured in the previously affected SCAD artery and 1 non-SCAD artery. CFR <2.5 was defined as diagnostic of coronary microvascular dysfunction. An abnormal index of microcirculatory resistance was defined as >25 units. Seventeen women underwent coronary reactivity testing (1 had chronic dissection and was excluded). All presented with myocardial infarction and 2 underwent coronary stenting during the initial SCAD event. Fibromuscular dysplasia was present in 70.6% upon screening renal, iliac, and cerebrovascular arteries. Twelve patients (70.6%) had CFR <2.5 and 13 (76.5%) had an index of microcirculatory resistance >25 in at least 1 artery. There was no difference in the frequency of a low CFR measurement between SCAD and non-SCAD arteries. Conclusions Among patients with chronic chest pain after an SCAD event, >70% had coronary microvascular dysfunction as indicated by abnormal CFR or index of microcirculatory resistance in at least 1 coronary artery on invasive coronary reactivity testing. Presence of coronary microvascular dysfunction in both SCAD and non-SCAD arteries suggests that underlying microvascular abnormalities from vasculopathies such as coronary fibromuscular dysplasia may be the underlying etiology.
尽管自发性冠状动脉夹层 (SCAD) 患者的夹层已愈合,但仍有相当一部分患者持续存在慢性胸痛。我们试图通过在心脏导管室进行冠状动脉反应性测试来确定冠状动脉微血管功能障碍是否导致 SCAD 后慢性胸痛。
18 名患者同意在 SCAD 后至少 3 个月进行冠状动脉反应性测试。在先前受累的 SCAD 动脉和 1 条非 SCAD 动脉中测量冠状动脉血流储备 (CFR) 和微血管阻力指数。CFR<2.5 定义为冠状动脉微血管功能障碍的诊断标准。异常的微血管阻力指数定义为>25 单位。17 名女性接受了冠状动脉反应性测试(1 名患有慢性夹层,被排除在外)。所有患者均出现心肌梗死,2 例在初始 SCAD 事件中接受了冠状动脉支架置入术。在筛查肾、髂和脑血管时,70.6%存在纤维肌性发育不良。12 例患者(70.6%)的 CFR<2.5,13 例(76.5%)至少 1 条动脉的微血管阻力指数>25。SCAD 动脉和非 SCAD 动脉之间 CFR 测量值较低的频率无差异。
在 SCAD 事件后出现慢性胸痛的患者中,>70%的患者存在冠状动脉微血管功能障碍,这表明在至少 1 条冠状动脉的侵入性冠状动脉反应性测试中,CFR 或微血管阻力指数异常。SCAD 和非 SCAD 动脉中均存在冠状动脉微血管功能障碍表明,血管病变(如冠状动脉纤维肌性发育不良)引起的潜在微血管异常可能是潜在病因。